Interactions between glutamate and capsaicin in inducing muscle pain and sensitization in humans
- 1 July 2008
- journal article
- research article
- Published by Wiley in European journal of pain
- Vol. 12 (5), 661-670
- https://doi.org/10.1016/j.ejpain.2007.10.013
Abstract
The aim of the study was to investigate the interaction between glutamate and capsaicin in inducing muscle pain and sensitization in humans. Fifteen male volunteers participated. Glutamate or capsaicin or isotonic saline, in a paired‐sequence order, was injected randomly into the right or left masseter muscle. Two injections were given in a double‐blinded design 25min apart in 1session/week over 4 weeks: saline (A1) followed by glutamate (A2), capsaicin (B1) followed by glutamate (B2), saline (C1) followed by capsaicin (C2), and glutamate (D1) followed by capsaicin (D2). The subjects drew the area of perceived pain and scored pain intensity on a 0–10 visual analogue scale (VAS). Pressure pain threshold (PPT) at the injection site, at a site 2‐cm away, and on the contralateral side, as well as pressure pain tolerance (PPTol) at the injection site and contralateral site, were also measured before and after injection and subsequently at 5‐min intervals. Paired t‐test analyses showed that the pain drawing area was significantly smaller in the B2 compared to the A2 condition (P =0.028), and significantly larger in the D2 compared to the C2 condition (P =0.027). It also revealed significantly lower VAS peak pain intensity (P =0.008) and smaller VAS area under the curve (P =0.003) for the B2 compared to the A2 condition, and significantly higher VAS peak pain (P =0.015) and larger VAS area under the curve (P =0.037) for the D2 compared to the C2 condition. There was a significant PPT and PPTol decrease at the injection site after glutamate or capsaicin injection (ANOVA: P 0.682) or for the D2 compared to the C2 condition (P >0.133). Significant PPT changes were also observed at the site 2cm away, but not on the contralateral side. In conclusion, these findings indicate that intramuscular administrations of glutamate and capsaicin interact and influence pain and sensitization of muscle nociceptors: glutamate causes a sensitization to subsequent administration of capsaicin, whereas capsaicin is associated with a desensitization to subsequent injection of glutamate. These findings support previous animal data.Keywords
This publication has 49 references indexed in Scilit:
- Systemic administration of monosodium glutamate elevates intramuscular glutamate levels and sensitizes rat masseter muscle afferent fibersPain, 2007
- Potentiation of glutamatergic synaptic transmission by protein kinase C‐mediated sensitization of TRPV1 at the first sensory synapseThe Journal of Physiology, 2007
- Sex-related differences in NMDA-evoked rat masseter muscle afferent discharge result from estrogen-mediated modulation of peripheral NMDA receptor activityNeuroscience, 2007
- Capsaicin differentially modulates voltage-activated calcium channel currents in dorsal root ganglion neurones of ratsBrain Research, 2005
- A human experimental capsaicin model for trigeminal sensitization. Gender-specific differencesPain, 2005
- VR1-, VRL-1- and P2X3 receptor-immunoreactive innervation of the rat temporomandibular jointBrain Research, 2004
- Activation of Peripheral NMDA Receptors Contributes to Human Pain and Rat Afferent Discharges Evoked by Injection of Glutamate into the Masseter MuscleJournal of Neurophysiology, 2003
- Effect of capsaicin on voltage-gated currents of trigeminal neurones in cell culture and slice preparationsActa Physiologica Hungarica, 2001
- Repetitive intradermal capsaicin: differential effect on pain and areas of allodynia and punctate hyperalgesiaSomatosensory & Motor Research, 2000
- The Cloned Capsaicin Receptor Integrates Multiple Pain-Producing StimuliNeuron, 1998